Vaccine coverage and adherence to EPI schedules in eight resource poor settings in the MAL-ED cohort study

Vaccine

Volumn 35, Issue 3, 2017, Pages 443-451

  Hoest, Christel ^a   Seidman, Jessica C ^a   Lee, Gwenyth ^b   Platts Mills, James A ^c   Ali, Asad ^d   Olortegui, Maribel Paredes ^e   Bessong, Pascal ^f   Chandyo, Ram ^g,h   Babji, Sudhir ⁱ   Mohan, Venkata Raghava ⁱ   Mondal, Dinesh ^j   Mahfuz, Mustafa ^j   Mduma, Estomih R ^k   Nyathi, Emanuel ^f   Abreu, Claudia ^l   Miller, Mark A ^a   Pan, William ^m   Mason, Carl J ⁿ   Knobler, Stacey L ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c UNIVERSITY OF VIRGINIA   (United States)

^d AGA KHAN UNIVERSITY   (Pakistan)

^e ASOCIACIÓN BENÉFICA PRISMA   (Peru)

^f UNIVERSITY OF VENDA   (South Africa)

^g TRIBHUVAN UNIVERSITY   (Nepal)

^h UNIVERSITY OF BERGEN   (Norway)

ⁱ CHRISTIAN MEDICAL COLLEGE   (India)

^j INTERNATIONAL CENTRE FOR DIARRHOEAL DISEASE RESEARCH   (Bangladesh)

^k HAYDOM LUTHERAN HOSPITAL   (Tanzania)

^l FEDERAL UNIVERSITY OF CEARÁ   (Brazil)

^m DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁿ ARMED FORCES RESEARCH INSTITUTE OF MEDICAL SCIENCES   (Thailand)

more..

Author keywords

EPI; Measles; Public health; Socioeconomic factors; Vaccine coverage; Vaccine timing

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; HEPATITIS B VACCINE; MEASLES VACCINE; POLIOMYELITIS VACCINE; VACCINE;

ARTICLE; BANGLADESH; BRAZIL; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; DEMOGRAPHY; DIPHTHERIA; EDUCATIONAL STATUS; FEMALE; FOLLOW UP; HAEMOPHILUS INFECTION; HEPATITIS B; HOUSEHOLD INCOME; HUMAN; INDIA; INFANT; MAJOR CLINICAL STUDY; MALE; MALNUTRITION; MEASLES; MEASLES VACCINATION; MEDICATION COMPLIANCE; MIDDLE INCOME COUNTRY; NEPAL; NEWBORN; PAKISTAN; PATIENT COMPLIANCE; PERTUSSIS; PERU; POLIOMYELITIS; PRIORITY JOURNAL; SOCIOECONOMICS; SOUTH AFRICA; TANZANIA; TETANUS; VACCINATION; AFRICA; DEVELOPING COUNTRY; IMMUNIZATION; SOUTH AMERICA; SOUTHEAST ASIA; VACCINATION COVERAGE;

AFRICA; ASIA, SOUTHEASTERN; COHORT STUDIES; DEVELOPING COUNTRIES; FOLLOW-UP STUDIES; HUMANS; IMMUNIZATION SCHEDULE; INFANT; INFANT, NEWBORN; MEDICATION ADHERENCE; SOUTH AMERICA; VACCINATION COVERAGE; VACCINES;

EID: 85006378299     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2016.11.075     Document Type: Article

References (31)

1. [1] Keja, K., et al. Expanded programme on immunization. World Health Stat Q 41:2 (1988), 59–63.
2. [2] Dietz, V.J., et al. Potential impact on vaccination coverage levels by administering vaccines simultaneously and reducing dropout rates. Arch Pediatr Adolesc Med 148:9 (1994), 943–949.
3. [3] WHO. WHO vaccine-preventable diseases: monitoring system. Global summary; 2014 [cited 2014 August 20]. Available from: http://apps.who.int/immunization_monitoring/globalsummary.
4. [4] WHO. Global vaccine action plan 2011–2020; 2013.
5. [5] Akmatov, M.K., Mikolajczyk, R.T., Timeliness of childhood vaccinations in 31 low and middle-income countries. J Epidemiol Community Health, 66(7), 2012, e14.
6. [6] Clark, A., Sanderson, C., Timing of children's vaccinations in 45 low-income and middle-income countries: an analysis of survey data. Lancet 373:9674 (2009), 1543–1549.
7. [7] The MAL-ED study: a multinational and multidisciplinary approach to understand the relationship between enteric pathogens, malnutrition, gut physiology, physical growth, cognitive development, and immune responses in infants and children up to 2 years of age in resource-poor environments. Clin Infect Dis 59:Suppl 4 (2014), S193–S206.
8. [8] Ahmed, T., et al. The MAL-ED cohort study in Mirpur, Bangladesh. Clin Infect Dis 59:Suppl 4 (2014), S280–S286.
9. [9] Bessong, P.O., et al. Development of the Dzimauli community in Vhembe district, Limpopo Province of South Africa, for the MAL-ED cohort study. Clin Infect Dis 59:Suppl 4 (2014), S317–S324.
10. [10] John, S.M., et al. Establishment of the MAL-ED birth cohort study site in Vellore, Southern India. Clin Infect Dis 59:Suppl 4 (2014), S295–S299.
11. [11] Lima, A.A., et al. Geography, population, demography, socioeconomic, anthropometry, and environmental status in the MAL-ED cohort and case-control study sites in Fortaleza, Ceara, Brazil. Clin Infect Dis 59:Suppl 4 (2014), S287–S294.
12. [12] Mduma, E.R., et al. The etiology, risk factors, and interactions of enteric infections and malnutrition and the consequences for child health and development study (MAL-ED): description of the Tanzanian site. Clin Infect Dis 59:Suppl 4 (2014), S325–S330.
13. [13] Shrestha, P.S., et al. Bhaktapur, Nepal: the MAL-ED birth cohort study in Nepal. Clin Infect Dis 59:Suppl 4 (2014), S300–S303.
14. [14] Turab, A., et al. Demographic, socioeconomic, and health characteristics of the MAL-ED network study site in rural Pakistan. Clin Infect Dis 59:Suppl 4 (2014), S304–S309.
15. [15] Yori, P.P., et al. Santa Clara de Nanay: the MAL-ED cohort in Peru. Clin Infect Dis 59:Suppl 4 (2014), S310–S316.
16. [16] Hoest, C., et al. Evaluating associations between vaccine response and malnutrition, gut function, and enteric infections in the MAL-ED cohort study: methods and challenges. Clin Infect Dis 59:Suppl 4 (2014), S273–S279.
17. [17] Psaki, S.R., et al. Measuring socioeconomic status in multicountry studies: results from the eight-country MAL-ED study. Popul Health Metr, 12(1), 2014, 8.
18. [18] Schoub, B.D., Introduction of inactivated polio vaccine (IPV) into the routine immunization schedule of South Africa. Vaccine 30:Suppl 3 (2012), C35–C37.
19. [19] Roberts, L., Is measles next?. Science, 348(6238), 2015 p. 958–61 and 63.
20. [20] Global vaccine action plan. Decade of vaccine collaboration. Vaccine 31:Suppl 2 (2013), B5–B31.
21. [21] de Vries, R.D., et al. Measles immune suppression: lessons from the macaque model. PLoS Pathog, 8(8), 2012, e1002885.
22. [22] Mina, M.J., et al. Long-term measles-induced immunomodulation increases overall childhood infectious disease mortality. Science 348:6235 (2015), 694–699.
23. [23] Weiss, W.M., Choudhary, M., Solomon, R., Performance and determinants of routine immunization coverage within the context of intensive polio eradication activities in Uttar Pradesh, India: Social Mobilization Network (SM Net) and Core Group Polio Project (CGPP). BMC Int Health Hum Rights, 13, 2013, 25.
24. [24] WHO. Polio global eradication initiative. Polio eradication and endgame strategic plan 2013–2018; 2013.
25. [25] Sheikh, S.S., Ali, S.A., Predictors of vaccination card retention in children 12–59 months old in Karachi, Pakistan. Oman Med J 29:3 (2014), 190–193.
26. [26] Miles, M., et al. Validity of vaccination cards and parental recall to estimate vaccination coverage: a systematic review of the literature. Vaccine 31:12 (2013), 1560–1568.
27. [27] WHO. Vaccine preventable diseases. Vaccine monitoring system. Global summary reference time series; 2013 [cited 2013 June 24th]. Available from: http://apps.who.int/immunization_monitoring/globalsummary/timeseries/tscoveragebcg.html.
28. [28] Lim, S.S., et al. Tracking progress towards universal childhood immunisation and the impact of global initiatives: a systematic analysis of three-dose diphtheria, tetanus, and pertussis immunisation coverage. Lancet 372:9655 (2008), 2031–2046.
29. [29] Fadnes, L.T., et al. Vaccination coverage and timeliness in three South African areas: a prospective study. BMC Publ Health, 11, 2011, 404.
30. [30] Barata, R.B., et al. Socioeconomic inequalities and vaccination coverage: results of an immunisation coverage survey in 27 Brazilian capitals, 2007–2008. J Epidemiol Commun Health 66:10 (2012), 934–941.
31. [31] de Waroux, O. Le Polain, et al. Timeliness and completeness of vaccination and risk factors for low and late vaccine uptake in young children living in rural southern Tanzania. Int Health 5:2 (2013), 139–147.